WD Hardie, CB Kerlakian, MD Bruno, KM Huelsman, SE Wert, SW Glasser, JA Whitsett and TR Korfhagen
Division of Pulmonary Biology, Children's Hospital Research Foundation, Cincinnati, Ohio 45229-3039, USA.

Transgenic mice expressing transforming growth factor alpha (TGF-alpha) in type II cells under control of the lung-specific surfactant protein- C (SP-C) promoter develop pulmonary fibrosis and marked airspace hypoplasia. To identify cellular signaling mechanisms involved in lesion formation, we generated transgenic mice expressing a mutant epidermal growth factor receptor lacking a portion of the intracytoplasmic domain (EGF-R-M) under control of the human SP-C promoter. Transcripts of the SP-C-EGF-R-M transgene were detected in distal bronchiolar and type II cells by in situ hybridization. The morphology of lungs from the SP-C-EGF-R-M transgenic mice was normal. Lung fibrosis was not detectable and airspace hypoplasia was significantly corrected in bitransgenic mice derived by breeding SP-C- TGF-alpha and SP-C-EGF-R-M mice. Correction of lung pathology in the bitransgenic mice occurred without altering the level of hTGF-alpha mRNA. To further demonstrate that reversal of TGF-alpha lesions required signaling through the EGF-R, SP-C-TGF-alpha transgenic mice were bred to mice homozygous for the wa-2 mutation which encodes a mutated EGF-R. TGF-alpha-induced lesions were reversed in homozygous wa- 2 mice. Amelioration of TGF-alpha-dependent pulmonary lesions in SP-C- EGF-R-M mice or wa-2/wa-2 mice supports the concept that autocrine and paracrine signaling mediate fibrosis and airspace remodeling caused by TGF-alpha.

This article has been cited by other articles:

				W. D. Hardie, C. Davidson, M. Ikegami, G. D. Leikauf, T. D. Le Cras, A. Prestridge, J. A. Whitsett, and T. R. Korfhagen EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-{alpha}-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1217 - L1225. [Abstract] [Full Text] [PDF]

				J. A. Faress, D. E. Nethery, E. F. O. Kern, R. Eisenberg, F. J. Jacono, C. L. Allen, and J. A. Kern Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2 J Appl Physiol, December 1, 2007; 103(6): 2077 - 2083. [Abstract] [Full Text] [PDF]

				W. D. Hardie, T. R. Korfhagen, M. A. Sartor, A. Prestridge, M. Medvedovic, T. D. Le Cras, M. Ikegami, S. C. Wesselkamper, C. Davidson, M. Dietsch, et al. Genomic Profile of Matrix and Vasculature Remodeling in TGF-{alpha} Induced Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 309 - 321. [Abstract] [Full Text] [PDF]

				M. R. Schneider, M. Dahlhoff, N. Herbach, I. Renner-Mueller, C. Dalke, O. Puk, J. Graw, R. Wanke, and E. Wolf Betacellulin Overexpression in Transgenic Mice Causes Disproportionate Growth, Pulmonary Hemorrhage Syndrome, and Complex Eye Pathology Endocrinology, December 1, 2005; 146(12): 5237 - 5246. [Abstract] [Full Text] [PDF]

				D. E. Nethery, B. B. Moore, G. Minowada, J. Carroll, J. A. Faress, and J. A. Kern Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice J Appl Physiol, July 1, 2005; 99(1): 298 - 307. [Abstract] [Full Text] [PDF]

				M. Ikegami, T. D. Le Cras, W. D. Hardie, M. T. Stahlman, J. A. Whitsett, and T. R. Korfhagen TGF-{alpha} perturbs surfactant homeostasis in vivo Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L34 - L43. [Abstract] [Full Text] [PDF]

				T. D. Le Cras, W. D. Hardie, K. Fagan, J. A. Whitsett, and T. R. Korfhagen Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-{alpha} Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1046 - L1054. [Abstract] [Full Text] [PDF]

				C. B. Manning, A. B. Cummins, M. W. Jung, I. Berlanger, C. R. Timblin, C. Palmer, D. J. Taatjes, D. Hemenway, P. Vacek, and B. T. Mossman A Mutant Epidermal Growth Factor Receptor Targeted to Lung Epithelium Inhibits Asbestos-induced Proliferation and Proto-Oncogene Expression Cancer Res., August 1, 2002; 62(15): 4169 - 4175. [Abstract] [Full Text] [PDF]

				S. J. DiCamillo, I. Carreras, M. V. Panchenko, P. J. Stone, M. A. Nugent, J. A. Foster, and M. P. Panchenko Elastase-released Epidermal Growth Factor Recruits Epidermal Growth Factor Receptor and Extracellular Signal-regulated Kinases to Down-regulate Tropoelastin mRNA in Lung Fibroblasts J. Biol. Chem., May 17, 2002; 277(21): 18938 - 18946. [Abstract] [Full Text] [PDF]

				W. D. Hardie, D. R. Prows, A. Piljan-Gentle, M. R. Dunlavy, S. C. Wesselkamper, G. D. Leikauf, and T. R. Korfhagen Dose-Related Protection from Nickel-Induced Lung Injury in Transgenic Mice Expressing Human Transforming Growth Factor-alpha Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 430 - 437. [Abstract] [Full Text] [PDF]

				W. D. Hardie, A. Piljan-Gentle, M. R. Dunlavy, M. Ikegami, and T. R. Korfhagen Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1088 - L1094. [Abstract] [Full Text] [PDF]

				C. Timblin, R. Robledo, M. Rincon, A. Cummins, L. Pfeiffer, and B. Mossman Transgenic Mouse Models To Determine the Role of Epidermal Growth Factor Receptor in Epithelial Cell Proliferation, Apoptosis, and Asbestosis Chest, July 1, 2001; 120(2007): 22S - 24S. [Full Text] [PDF]

				A. Nelson, T. Mendoza, G. W. Hoyle, A. R. Brody, C. Fermin, and G. F. Morris Enhancement of Fibrogenesis by the p53 Tumor Suppressor Protein in Asbestos-Exposed Rodents Chest, July 1, 2001; 120(2007): 33S - 34S. [Full Text] [PDF]

				F. TERZI, M. BURTIN, and G. FRIEDLANDER Using Transgenic Mice to Analyze the Mechanisms of Progression of Chronic Renal Failure J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 144S - 148. [Abstract] [Full Text]

				R. F. Robledo, S. A. Buder-Hoffmann, A. B. Cummins, E. S. Walsh, D. J. Taatjes, and B. T. Mossman Increased Phosphorylated Extracellular Signal-Regulated Kinase Immunoreactivity Associated with Proliferative and Morphologic Lung Alterations after Chrysotile Asbestos Inhalation in Mice Am. J. Pathol., April 1, 2000; 156(4): 1307 - 1316. [Abstract] [Full Text] [PDF]

				B. B. Warner, L. A. Stuart, R. A. Papes, and J. R. Wispe Functional and pathological effects of prolonged hyperoxia in neonatal mice Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L110 - L117. [Abstract] [Full Text] [PDF]